| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ASCO 2021—an update on metastastic colorectal cancer
|
Weiss, Lukas
|
|
|
14 |
4 |
p. 319-322
|
artikel
|
| 2 |
ASCO 2021–Gastroesophageal tumor highlights
|
Ilhan-Mutlu, Aysegül
|
|
|
14 |
4 |
p. 338-341
|
artikel
|
| 3 |
ASCO 2021 highlights head and neck cancer: nasopharyngeal carcinoma
|
Fuereder, Thorsten
|
|
|
14 |
4 |
p. 331-334
|
artikel
|
| 4 |
ASCO 2021: Highlights in central nervous system tumors
|
Mair, Maximilian J.
|
|
|
14 |
4 |
p. 323-327
|
artikel
|
| 5 |
ASCO 2021—selection of personal highlights in early stage non-small cell lung cancer
|
Absenger, Gudrun
|
|
|
14 |
4 |
p. 347-349
|
artikel
|
| 6 |
Best of ASCO 2021
|
Wöll, Ewald
|
|
|
14 |
4 |
p. 313-314
|
artikel
|
| 7 |
Best of ASCO 2021—bladder cancer
|
Mayrhofer, Karl
|
|
|
14 |
4 |
p. 335-337
|
artikel
|
| 8 |
Best of ASCO 2021: new data from triple-negative breast cancer
|
Singer, Christian
|
|
|
14 |
4 |
p. 328-330
|
artikel
|
| 9 |
Detection of acquired resistance mutation ALK G1202R after treatment with alectinib and response of lorlatinib
|
Hempel, Louisa
|
|
|
14 |
4 |
p. 386-391
|
artikel
|
| 10 |
Is thymus and activation-regulated chemokine a forgotten diagnostic and minimal residual disease marker in classical Hodgkin lymphoma?
|
Khair, Wael
|
|
|
14 |
4 |
p. 406-411
|
artikel
|
| 11 |
Laboratory thrombophilia screening: essentials for hematologists
|
Kyrle, Paul A.
|
|
|
14 |
4 |
p. 360-363
|
artikel
|
| 12 |
Neuroendocrine neoplasms of the lung: a pathology update
|
Metovic, Jasna
|
|
|
14 |
4 |
p. 381-385
|
artikel
|
| 13 |
Ovarian cancer—ASCO annual meeting update 2021
|
Schöche, Johannes
|
|
|
14 |
4 |
p. 342-346
|
artikel
|
| 14 |
Pancytopenia—a diagnostic challenge?
|
Geissler, Klaus
|
|
|
14 |
4 |
p. 355-359
|
artikel
|
| 15 |
Ponatinib and palbociclib combination in TKI-resistant CML—A case report
|
Jaeger, Johannes B.
|
|
|
14 |
4 |
p. 402-405
|
artikel
|
| 16 |
Practical considerations for the management of immune thrombocytopenic purpura
|
Fillitz, Michael
|
|
|
14 |
4 |
p. 350-354
|
artikel
|
| 17 |
Practical issues in hematology
|
Geissler, Klaus
|
|
|
14 |
4 |
p. 315-316
|
artikel
|
| 18 |
Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report
|
Nagl, Laurenz
|
|
|
14 |
4 |
p. 392-396
|
artikel
|
| 19 |
Rare lung cancers—2021 update on challenges, advances, and opportunities
|
Pircher, Andreas
|
|
|
14 |
4 |
p. 317-318
|
artikel
|
| 20 |
The double-edged sword of immune checkpoint inhibition in advanced staged thymic epithelial tumours
|
Jungraithmayr, Wolfgang
|
|
|
14 |
4 |
p. 373-375
|
artikel
|
| 21 |
The value of immunotherapy in pediatric leukemia and lymphoma
|
Salzer, Elisabeth
|
|
|
14 |
4 |
p. 397-401
|
artikel
|
| 22 |
Unresectable pleural mesothelioma—hope or still an unmet medical need?
|
Absenger, Gudrun
|
|
|
14 |
4 |
p. 376-380
|
artikel
|
| 23 |
Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL)
|
Ibrahim, Rasha I.
|
|
|
14 |
4 |
p. 364-372
|
artikel
|
Tijdschrift beschrijving